Part two of this four part video series from J&J highlights long-acting injectable (LAI) antipsychotics as a treatment option for schizophrenia. Unlike daily oral medications, LAIs are given every few weeks or months, which may help with consistent treatment, reduce relapses, and support stable symptom management. The event features research findings, perspectives from mental health professionals, and experiences from patients to discuss the potential role of LAIs in improving care for people living with schizophrenia.
To learn more, watch the video here.
Contributor: Johnson & Johnson – Dr. Christoph Correll, Dr. Leslie Citrome, Dr. Diana Perkins
